Open AccessPembrolizumab Improves Event-Free Survival in TNBC Patients
Author(s) -
Catlin Nalley
Publication year - 2021
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000796292.29635.62
Subject(s) - pembrolizumab , medicine , breast cancer , oncology , chemotherapy , triple negative breast cancer , disease , population , neoadjuvant therapy , cancer , stage (stratigraphy) , immunotherapy , paleontology , environmental health , biology